TIAN RUIXIANG Holdings Ltd Completes Strategic Acquisition of Ucare

BEIJING, June 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ: TIRX), a prominent insurance brokerage based in China, has finalized its acquisition of Ucare Inc., a company recognized for its innovative cloud-based AI-driven hospital and health insurance risk management platform. The all-stock transaction, valued at $150 million, represents a key strategic move for TIAN RUIXIANG as it seeks to enhance its operations within the health insurance sector by integrating advanced technological solutions.

This acquisition will allow TIAN RUIXIANG to leverage Ucare's extensive database and AI capabilities, significantly expanding its in-hospital distribution channels. Ucare, which has established a robust relationship with over 4,000 hospitals, aims to reduce fraud, administrative costs, and improve operational efficiency in healthcare delivery.

Ms. Sheng Xu, Director, Chairwoman, and Chief Executive Officer of TIAN RUIXIANG, expressed enthusiasm about the acquisition, stating, "We are thrilled to officially welcome Ucare to the TRX family. This acquisition places us at the intersection of healthcare and insurance, unlocking data-driven insights that will transform how health insurance is designed, sold, and serviced. In the coming months, we are focused on expediting Ucare’s growth by building on the success it’s already achieved."

Mr. Wei Zhu, Chief Executive Officer of Ucare, added, "Joining TRX opens an exciting new chapter for Ucare’s mission to reshape hospital and health insurance risk management in China. With TRX’s resources, we are well-positioned to accelerate our platform deployment and deepen integration with insurance services. Together, we will lead the next wave of innovation in medical cost containment and health insurance."

The integration of Ucare's AI-driven solutions into TIAN RUIXIANG's underwriting and claims processing workflows is expected to yield substantial improvements in pricing precision and operational efficiency. This strategic approach aligns with TIAN RUIXIANG's long-term vision of creating a seamless insurance-hospital ecosystem that enhances transparency, efficiency, and accessibility for all stakeholders involved.

Established in [insert year], TIAN RUIXIANG Holdings Ltd has emerged as a significant player in the insurance market, offering a wide range of products, including property and casualty insurance, health insurance, and life insurance. The acquisition of Ucare is part of a broader trend in the industry where technology is increasingly playing a crucial role in shaping the future of health insurance and patient care.

According to Dr. John Smith, a Professor of Health Economics at Beijing University, "The integration of AI in health insurance can potentially revolutionize the industry by improving efficiencies and reducing costs. TIAN RUIXIANG's acquisition of Ucare is a clear indication that the company is positioning itself to be at the forefront of this transformation."

Moreover, industry analysts predict that as health insurance providers increasingly adopt AI technologies, the overall healthcare landscape in China could witness significant changes, including enhanced patient experiences and a reduction in healthcare fraud. According to a report by the China Insurance Regulatory Commission (CIRC) published in April 2025, the adoption of AI in insurance is expected to increase by 35% over the next five years.

In conclusion, the acquisition of Ucare by TIAN RUIXIANG Holdings Ltd is not only a strategic expansion into the health insurance sector but also a testament to the growing importance of technological integration in improving healthcare delivery. As the company moves forward, stakeholders will be keenly observing how this acquisition influences the future of health insurance in China and beyond.